Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)

Gregory Y H Lip; Flemming Skjøth; Lars Hvilsted Rasmussen; Peter B Nielsen; Torben Bjerregaard Larsen

doi:10.1016/j.jacc.2015.05.044

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)

Gregory Y H Lip, Flemming Skjøth, Lars Hvilsted Rasmussen, Peter B Nielsen, Torben Bjerregaard Larsen

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Journal of the American College of Cardiology
Volume	66
Issue number	4
Pages (from-to)	488-490
Number of pages	3
ISSN	0735-1097
DOIs	https://doi.org/10.1016/j.jacc.2015.05.044
Publication status	Published - 2015

Access to Document

10.1016/j.jacc.2015.05.044

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Lip, G. Y. H., Skjøth, F., Rasmussen, L. H., Nielsen, P. B., & Larsen, T. B. (2015). Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex). Journal of the American College of Cardiology, 66(4), 488-490. https://doi.org/10.1016/j.jacc.2015.05.044

@article{a194de5a4832480385ae63142ce34c29,

title = "Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)",

author = "Lip, {Gregory Y H} and Flemming Skj{\o}th and Rasmussen, {Lars Hvilsted} and Nielsen, {Peter B} and Larsen, {Torben Bjerregaard}",

year = "2015",

doi = "10.1016/j.jacc.2015.05.044",

language = "English",

volume = "66",

pages = "488--490",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier",

number = "4",

}

Lip, GYH , Skjøth, F , Rasmussen, LH , Nielsen, PB & Larsen, TB 2015, 'Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)', Journal of the American College of Cardiology, vol. 66, no. 4, pp. 488-490. https://doi.org/10.1016/j.jacc.2015.05.044

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex). / Lip, Gregory Y H ; Skjøth, Flemming ; Rasmussen, Lars Hvilsted et al.
In: Journal of the American College of Cardiology, Vol. 66, No. 4, 2015, p. 488-490.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)

AU - Lip, Gregory Y H

AU - Skjøth, Flemming

AU - Rasmussen, Lars Hvilsted

AU - Nielsen, Peter B

AU - Larsen, Torben Bjerregaard

PY - 2015

Y1 - 2015

U2 - 10.1016/j.jacc.2015.05.044

DO - 10.1016/j.jacc.2015.05.044

M3 - Letter

C2 - 26205604

SN - 0735-1097

VL - 66

SP - 488

EP - 490

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 4

ER -